Compounds > tamibarotene
Page last updated: 2024-09-02

tamibarotene and Multiple Myeloma

tamibarotene has been researched along with Multiple Myeloma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukui, T; Kodera, Y; Koizumi, F; Masuda, N; Nishio, K; Tamura, T1
Iida, S; Ishida, T; Komatsu, H; Kuwano, M; Kuwano, T; Nakao, S; Ono, M; Sanda, T; Shudo, K; Ueda, R1
Iida, S; Kayukawa, S; Sanda, T; Ueda, R1

Other Studies

3 other study(ies) available for tamibarotene and Multiple Myeloma

ArticleYear
Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells.
    Cancer science, 2009, Volume: 100, Issue:6

    Topics: Animals; Antineoplastic Agents; Benzoates; Cell Division; Cell Line, Tumor; Cell Survival; Drug Synergism; Female; Glucocorticoids; Humans; Mice; Mice, SCID; Multiple Myeloma; Retinoids; Tetrahydronaphthalenes; Tretinoin

2009
Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis.
    Leukemia, 2005, Volume: 19, Issue:6

    Topics: Animals; Benzoates; Cell Division; Cell Line, Tumor; Cell Movement; Coculture Techniques; Cornea; Down-Regulation; Endothelium, Vascular; Hematopoietic Stem Cells; Humans; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Multiple Myeloma; Neovascularization, Pathologic; NIH 3T3 Cells; Phosphorylation; Receptors, Interleukin-6; Receptors, Vascular Endothelial Growth Factor; Retinoids; Tetrahydronaphthalenes; Umbilical Veins; Vascular Endothelial Growth Factor A

2005
Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid.
    Haematologica, 2007, Volume: 92, Issue:1

    Topics: Anticarcinogenic Agents; Benzoates; Cell Line, Tumor; Cell Proliferation; DNA, Complementary; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, MHC Class II; Histocompatibility Antigens Class II; Humans; Jurkat Cells; Multiple Myeloma; NF-kappa B; Oligonucleotide Array Sequence Analysis; Retinoids; Tetrahydronaphthalenes

2007